Molina: 3 Key Takeaways for Long-Term Investors

Molina reaffirmed its adjusted earnings guidance of at least $5.25 per share for the fiscal year 2026 during its Q3 2026 earnings call held on October 22, 2026. The company is grappling with rising medical costs in its government-sponsored health insurance plans, but rate adjustments from state partners are helping to stabilize underlying operating margins.

Key points highlighted by Molina management include the alignment of state reimbursement rates with the increased care expenses, which has stabilized profitability in core Medicaid coverage for low-income residents. A new contract implementation, the $6 billion Florida specialized children's health program, is expected to generate predictable profit growth as initial setup costs become normalized, potentially adding $4 per share of embedded earnings in 2027.

Flexibility from state regulators in implementing Centers for Medicare & Medicaid Services (CMS) guidance is minimizing coverage disruptions and supporting consistent enrollment. According to Molina, about 80% of its states are currently favoring policies that encourage enrollment rather than disenrollment. The company is also benefiting from disciplined bidding on Request for Proposal (RFP) awards and strong positioning in duals programs, which serve patients eligible for both Medicare and Medicaid, providing structural tailwinds.

Molina's leadership is closely monitoring state rating discipline and medical utilization trends. With medical cost trends appearing to plateau at elevated levels and recent rate updates, the company believes it is entering the beginning of a turn in Medicaid margins. The company's disciplined contract backlog execution and expense efficiency efforts are paving the way for profitable growth in the coming multi-year cycle.